181 related articles for article (PubMed ID: 10881375)
1. Multicentric Castleman's disease in 2 patients with HIV infection, unresponsive to antiviral therapy.
Bottieau E; Colebunders R; Schroyens W; Van Droogenbroeck J; De Droogh E; Depraetere K; De Raeve H; Van Marck E
Acta Clin Belg; 2000; 55(2):97-101. PubMed ID: 10881375
[TBL] [Abstract][Full Text] [Related]
2. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of Castleman's disease with HAART in two HIV-infected patients.
Lanzafame M; Carretta G; Trevenzoli M; Lazzarini L; Vento Ercole Concia S
J Infect; 2000 Jan; 40(1):90-1. PubMed ID: 10762119
[TBL] [Abstract][Full Text] [Related]
4. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
[TBL] [Abstract][Full Text] [Related]
5. Central pontine myelinolysis complicating treatment of multicentric Castleman's disease and Kaposi's sarcoma in a patient with AIDS.
Apoola A; Ross J; Duddy MJ; Mudaliar V; Jones EL; Huengsberg M; Miller RF
Sex Transm Infect; 2003 Jun; 79(3):179-84. PubMed ID: 12794197
[TBL] [Abstract][Full Text] [Related]
6. Potential heterosexual Kaposi's sarcoma-associated herpesvirus transmission in a couple with HIV-induced immunodepression and with Kaposi's sarcoma and multicentric Castleman's disease.
Tirelli U; Gaidano G; Errante D; Carbone A
AIDS; 1996 Sep; 10(11):1291-2. PubMed ID: 8883593
[No Abstract] [Full Text] [Related]
7. HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution.
Volkow-Fernández P; Lome-Maldonado C; Quintero-Buenrostro H; Islas-Muñoz B; Cornejo-Juárez P
Int J STD AIDS; 2020 Mar; 31(4):318-325. PubMed ID: 32089093
[No Abstract] [Full Text] [Related]
8. Outcomes in Kaposi's sarcoma-associated herpesvirus -associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety-net hospital system.
Lopez M; Kainthla R; Lazarte S; Chen W; Nijhawan AE; Knights S
Eur J Haematol; 2024 May; 112(5):723-730. PubMed ID: 38155405
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV-infected patient under viral suppression.
Lin IF; Lin JN; Tsai TH; Hsu CT; Wu YY; Lai CH
Int J STD AIDS; 2021 Mar; 32(3):286-289. PubMed ID: 33555231
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous Kaposi's sarcoma and Castleman's disease in a HIV-negative patient. Response to rituximab and doxorubicin.
García-Arpa M; Calle-Primo C; Martín-Dávila F
Med Clin (Barc); 2020 Dec; 155(12):565-566. PubMed ID: 31759694
[No Abstract] [Full Text] [Related]
11. Kaposi's sarcoma associated with Castleman's disease.
Zeidman A; Fradin Z; Cohen AM; Mittelman M
Eur J Haematol; 1999 Jul; 63(1):67-70. PubMed ID: 10414458
[No Abstract] [Full Text] [Related]
12. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.
Aoki Y; Tosato G
Expert Rev Anti Infect Ther; 2004 Apr; 2(2):213-25. PubMed ID: 15482187
[TBL] [Abstract][Full Text] [Related]
14. Fatal Castleman's disease and pulmonary Kaposi's sarcoma in an HIV-seropositive woman.
Wynia MK; Shapiro B; Kuvin JT; Skolnik PR
AIDS; 1995 Jul; 9(7):814-6. PubMed ID: 7546432
[No Abstract] [Full Text] [Related]
15. Plasma Cell Variant Multicentric Castleman Disease and Kaposi's Sarcoma in a Treatment-Naive HIV-Infected Patient.
Patel AS; Geller RL; Goswami ND
AIDS Res Hum Retroviruses; 2018 Feb; 34(2):127-128. PubMed ID: 29345958
[No Abstract] [Full Text] [Related]
16. [Favorable outcome of Castleman's disease treated with oral valganciclovir].
Valencia ME; Moreno V; Martínez P; Casado I
Med Clin (Barc); 2005 Sep; 125(10):399. PubMed ID: 16185555
[No Abstract] [Full Text] [Related]
17. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
Murphy C; Hawkes E; Chionh F; Chong G
J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
[TBL] [Abstract][Full Text] [Related]
18. Multicentric Castleman's disease treated with antivirals and immunosuppressants.
Senanayake S; Kelly J; Lloyd A; Waliuzzaman Z; Goldstein D; Rawlinson W
J Med Virol; 2003 Nov; 71(3):399-403. PubMed ID: 12966545
[TBL] [Abstract][Full Text] [Related]
19. Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin.
Torre-Cisneros J; Pozo F; Serrano R; Vidal E; Rivero A; Tenorio A
AIDS; 2000 Sep; 14(14):2215-7. PubMed ID: 11061671
[No Abstract] [Full Text] [Related]
20. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma.
Bower M; Fox P; Fife K; Gill J; Nelson M; Gazzard B
AIDS; 1999 Oct; 13(15):2105-11. PubMed ID: 10546864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
